Author

Annabelle Ballesta

InsermORCID 0000-0001-7204-1205Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:statistical model· 3 Assay:bulk RNA-seq· 2 Approach:deep learning· 2 Research Focus:drug response / drug discovery· 2 Research Focus:benchmarking· 1 Assay:proteomics· 1

Frequent Co-Authors

Ahmed IdbaïhiD· 1 shared C. Duong-NgoiD· 1 shared Cécile CarrèreiD· 1 shared Clémence AstieriD· 1 shared Daphné MoreliD· 1 shared Elaine Del NeryiD· 1 shared Elodie Anthony· 1 shared Françis LéviiD· 1 shared

Activity by Year

2020-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ahmed IdbaïhORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Circumventing glioblastoma resistance to temozolomide through optimal drug combinations designed by quantitative systems pharmacology and machine learning

Sergio Corridore, Maïté Verreault, Hugo Martin, Thibault Delobel, Cécile Carrère, Ahmed Idbaïh, Annabelle Ballesta

British Journal of Pharmacology · Apr 14, 2025Peer-reviewedCancer Biology

Integrated multiomic profiling reveals SWI/SNF subunit-specific pathway alterations and targetable vulnerabilities

Jorge Bretones Santamarina, Clémence Astier, Marlène Garrido, Leo Colmet Daage, Theodoros I. Roumeliotis, Elodie Anthony, Mercedes Pardo, Marianne Chasseriaud, Pierre Gestraud, C. Duong-Ngo, Daphné Morel, Roman M. Chabanon, Jyoti S. Choudhary, Elaine Del Nery, Sophie C. Postel-Vinay, Annabelle Ballesta

The paper identifies pathway alterations and targetable vulnerabilities in SWI/SNF-defective cancers through multiomic profiling and drug screening.

bioRxiv · Jul 16, 2024 · PreprintCancer Biology

Optimizing circadian drug infusion schedules towards personalized cancer chronotherapy

Roger J. W. Hill, Pasquale F. Innominato, Françis Lévi, Annabelle Ballesta

This paper develops a mathematical framework to optimize drug infusion pumps and analyze inter-patient pharmacokinetic variability for personalized cancer chronotherapy.

PLoS Computational Biology · Jan 27, 2020Peer-reviewedSystems Biology